Results 171 to 180 of about 996,145 (295)

Selected Screening Tests for Genetic Metabolic Diseases [PDF]

, 1975
D. N. Raine
openalex   +1 more source

Therapeutic Potential of Infrared and Related Light Therapies in Metabolic Diseases. [PDF]

Int J Mol Sci
Nowacka A, Śniegocki M, Smuczyński W, Ziółkowska E.   +3 more
europepmc   +1 more source

Genetic and Metabolic Eye Disease [PDF]

, 1976
B. Jay
openalex   +1 more source

Medication Use in Multiple Sclerosis: A Population‐Based Comparison With the General Danish Population

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate the overall use of prescription medications among individuals with multiple sclerosis compared to the general population, with a focus on treatments beyond disease‐modifying therapies. Methods We conducted a nationwide, registry‐based study in Denmark.
Josefine Windfeld‐Mathiasen, Henrik Horwitz, Ida M. Heerfordt, Elisabeth Framke, Melinda Magyari   +4 more
wiley   +1 more source

Fructose metabolism and its roles in metabolic diseases, inflammatory diseases, and cancer. [PDF]

Mol Biomed
Li Z, Fan X, Gao F, Pan S, Ma X, Cheng H, Nakatsukasa H, Zhang W, Zhang D.   +8 more
europepmc   +1 more source

Book Review: Metabolic and Nutritional Eye Diseases [PDF]

, 1970
Michael Bedford
openalex   +1 more source

The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate whether the rs10191329 risk allele in the DYSF–ZNF638 locus, which is implicated in central nervous system resilience rather than immune‐mediated pathology, is associated with retinal layer thinning, a biomarker of neuroaxonal damage in relapsing multiple sclerosis (RMS). Methods From a prospective observational study,
Gabriel Bsteh, Ruchi Tanavade, Nik Krajnc, Fabian Föttinger, Theresa König, Martin Krenn, Lukas Haider, Barbara Kornek, Fritz Leutmezer, Kerstin U. Ludwig, Stefan Macher, Tobias Monschein, Markus Ponleitner, Paulus Rommer, Christiane Schmied, Karin Zebenholzer, Tobias Zrzavy, Gudrun Zulehner, Franziska Di Pauli, Axel Schmidt, Harald Hegen, Berthold Pemp, Thomas Berger   +22 more
wiley   +1 more source

Are protein substitutes available in Italy for infants with inherited metabolic diseases all the same? [PDF]

Front Nutr
Di Costanzo M, Tosi M, Muzi M, Buono EV, D'Onghia V, Munerati A, Tarditi G, Bruni S, Verduci E, Biasucci G.   +9 more
europepmc   +1 more source

Recent Advances in the Unerstanding and Management of Metabolic Bone Disease [Abridged] [PDF]

, 1970
Roger Smith
openalex   +1 more source

Quantitative Iron Measurements in the Basal Ganglia of NBIA Patients Using QSM: Insights From a Tertiary Center

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurodegeneration with brain iron accumulation (NBIA) comprises rare genetic disorders characterized by predominantly extrapyramidal symptoms and iron deposition in the basal ganglia. Conventional magnetic resonance imaging (MRI) detects qualitative changes but cannot accurately quantify iron accumulation. Quantitative susceptibility
Özge Uygun, Alpay Özcan, Fuat Kaan Aras, Evrim Bozdemir, Sibel Uğur İşeri, Murat Gültekin, Nihan Hande Akçakaya, Orkhan Mammadov, Gülay Kır, Dilek İnce Günal, Neşe Tuncer, Fatma Betül Özdilek, Banu Özen Barut, Ercan Köse, Hülya Apaydın, Asuman Ali, Sultan Çağırıcı, Pınar Topaloğlu, Alp Dinçer, Zuhal Yapıcı   +19 more
wiley   +1 more source